| Scientific publications by Santaris Pharma in 2003 |
| |
Synthesis of 2'-amino-LNA: a new strategy
Rosenbohm C Christensen SM, Sorensen MD, Pedersen DS, Larsen LE , Wengel J and Koch T
Org Biomol Chem 2003 1(4): 655-663 |
|
Improved synthesis of 2'-amino-LNA
Christensen SM, Rosenbohm C, Sorensen M, Larsen L E, Wengel J and Koch T
Nucleosides Nucleotides Nucleic Acids 2003 22(5-8): 1131-1133 |
|
New standars in LNA synthesis
Hansen HF, Olsen O and Koch T Nucleosides Nucleotides Nucleic Acids 2003 22(5-8): 1273-1275 |
|
Antisense knockdown of PKC-alpha using LNA-oligos
Hansen J B, Westergaard M, Thrue CA, Giwercman B and Orum H Nucleosides Nucleotides Nucleic Acids 2003 22(5-8): 1607-1609 |
|
Oligodesign: Optimal design of LNA (Locked Nucleic Acid) oligonucleotide capture probes for gene expression profiling.
Tolstrup N, Nielsen PS, Kolberg JG, Frankel AM, Vissing H and Kauppinen S
Nucleic Acids Res 2003, 31(13): 3758-3762 |
|
Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA
Frieden M, Christensen SM, Mikkelsen ND , Rosenbohm C , Thrue CA, Westergaard M, Hansen HF, Orum H and Koch T
Nucleic Acids Res 2003 31(21): 6365-6372 |
|
Nuclease stability of LNA oligonucleotides and LNA-DNA Chimeras
Frieden M , Hansen HF and Koch T Nucleosides, Nucleotides and Nucleic Acids 2003 22: 1041-1043 |
|
In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides
Fluiter K, Asbroek ALMA, de Wissel MB, Jakobs ME, Wissenbach M, Olsson H, Olsen O, Orum H and Baas F
Nucleic Acids Res 2003 31: 953-962 |
|
|
| |
|
